This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Q2 sales rise 33%, profit swings to Rs 17.36 crore
DCMNVL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.8 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
For the quarter ended September 30, 2026, DCM Nouvelle's consolidated sales rose 33.1% to Rs 318.02 crore, turning a Rs 2.05 crore loss into Rs 17.36 crore profit. Standalone sales rose 33.6% to Rs 314.12 crore and profit reached Rs 22.62 crore versus Rs 1.88 crore. In H1, consolidated sales rose 23.2% to Rs 605.45 crore and profit reached Rs 63.06 crore. Operating cash flow was Rs 122.07 crore. Auditors raised no issues.
Strong sales growth and a sharp profit turnaround are positive for shareholders, although the loss-making chemicals unit remains a concern.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹318.0 Cr | ₹238.9 Cr | +33.1% |
| Operating profit | ₹22.83 Cr | −₹2.68 Cr | turned positive |
| Profit after tax | ₹17.40 Cr | −₹2.42 Cr | turned positive |
| EBITDA margin | 11.0% | 3.8% | +7.2 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.